Until recently, researchers and oncologists had placed lung cancer patients into two broad categories: those who would benefit from immunotherapy, and those who likely would not. Now, researchers, using artificial intelligence (AI) to analyze simple tissue scans, say they have discovered biomarkers Read More>>
Categories
